plicamycin has been researched along with Carcinoma, Anaplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belka, C; Daniel, PT; Essmann, F; Gillissen, B; Hemmati, PG; Overkamp, T; Preissner, R; Richter, A | 1 |
| Hu, LJ; Kuang, BH; Li, MZ; Wang, HB; Xie, B; Xu, LH; Zhang, X; Zhao, WF | 1 |
2 other study(ies) available for plicamycin and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent 'type I' mode.
Topics: Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Carcinoma; Caspase 3; Caspase 8; Colonic Neoplasms; Drug Resistance, Neoplasm; HCT116 Cells; Humans; Oligopeptides; Plicamycin; Proteasome Endopeptidase Complex; RNA Interference; RNA, Small Interfering; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand; X-Linked Inhibitor of Apoptosis Protein | 2013 |
Sp1 and Sp3 are involved in the full transcriptional activity of centromere protein H in human nasopharyngeal carcinoma cells.
Topics: Base Sequence; Binding Sites; Carcinoma; Cell Line, Tumor; Chromosomal Proteins, Non-Histone; Cloning, Molecular; Gene Knockdown Techniques; Humans; Mutagenesis, Site-Directed; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Plicamycin; Promoter Regions, Genetic; Recombinant Proteins; Regulatory Elements, Transcriptional; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Sp1 Transcription Factor; Sp3 Transcription Factor | 2012 |